Lindis Biotech is a clinical stage bio-pharmaceutical company that is committed to the development of Triomab® antibodies – a new class of T-cell engaging bispecific antibodies, empowering the immune system to turn malignant cancers into manageable and possibly curable diseases.
We combine scientific & pharmaceutical experience. We engage for safe and efficacious biomedical products.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.